Actual News History Analyses Other

Delft Instruments News



profile

quote

news
-

 Wednesday January 9 2002
Delft Instruments definitely acquired Contrec in Australia
Delft Instruments N.V. confirms that the earlier announced acquisition of all Contrec Pty. shares has been effected on 9 January 2002. Contrec is located in Melbourne, Australia and develops and manufactures instrumentation equipment, systems and software for the process-, oil- and gasindustries. Contrec is an expert in Fuel Management Systems used in tankfarms within the petrochemical industry.

Thursday January 3 2002
Delft Instruments increase interest in Rogan Medical Systems to 70%
Delft Instruments N.V. announces that it has increased its interest in Rogan Medical Systems B.V., Zeist, Netherlands, from 52% to 70% as from 2 January 2002. The transaction will be paid in cash out of the current cash flow. Rogan Medical Systems develops software for PACS (Picture Archiving & Communication Systems), the world market for which is currently worth upwards of USD 3 bn and is showing a strong growth.

Monday December 3 2001
Delft Instruments acquires CONTREC PTY LTD in Australia
Delft Instruments N.V. announces that they have reached agreement with the shareholders and management of Contrec Pty about the acquisition of all Contrec shares. Contrec is located in Melbourne, Australia (www.Contrec.com.au) and develops and manufactures instrumentation equipment, systems and software for the process-, oil- and gasindustries.

Thursday October 25 2001
Nucletron receives marketing clearance for the Seedselectron
Delft Instruments N.V. announces that it's subsidiary Nucletron B.V. has received clearance by the Food and Drug Administration (FDA) in the USA to begin marketing the seedSelectron©, its innovative solution for permanent seed implant prostate therapy. The system significantly minimises the preparation time for the operation and it is designed to offer maximum radiation protection for the staff in the operating theatre.

Nucletron receives marketing clearance for the SEEDSELECTRON
Delft Instruments N.V. announces that it's subsidiary Nucletron B.V. has received clearance by the Food and Drug Administration (FDA) in the USA to begin marketing the seedSelectron©, its innovative solution for permanent seed implant prostate therapy. The system significantly minimises the preparation time for the operation and it is designed to offer maximum radiation protection for the staff in the operating theatre.

Wednesday February 7 2001
Delft Instruments provisional results for 2000 in line with expectations
Delft Instruments N.V. announces that the forecast made in the half-year report published on 24 August 2000 to the effect that the result on ordinary activities (after tax) for 2000 would turn out slightly higher than in 1999 has proved correct. This result was achieved despite the fact that sales were depressed owing to hold-ups in supplies of products and components by third parties.

Tuesday January 2 2001
Delft instruments acquires majority interest in Rogan Medical Systems B.V.
Delft Instruments is pleased to announce that it has increased its interest in Rogan Medical Systems B.V., Zeist, Netherlands, from 35% to 52% as from 1 January 2001. Rogan Medical Systems, which has a staff of 17, develops software for PACS (Picture Archive & Communication Systems), the world market for which is currently worth around USD 3 bn and is growing at an average of 30% per year.

Monday December 4 2000
Delft Instruments finalizes sale of Mechanical Parts Production to Hit Groep
Further to the press release of September 29, 2000, Delft Instruments N.V. announces that the transfer of shares of its subsidiary MPP to Hit Groep B.V. took place on December 1. The activities of MPP will be deconsolidated as from July 1, 2000, and the results have been accounted for by Hit Groep since then.

Tuesday October 3 2000
Oldelft Benelux BV wins major order from Military Medical Logistics Centre
Oldelft Benelux B.V., the Delft Instruments N.V. subsidiary which supplies medical imaging equipment, has won an order for around 300 patient monitoring units from the Military Medical Logistics Centre in Heerenveen, Netherlands. Oldelft Benelux B.V. secured the order following a European tendering procedure organised by the Netherlands Purchasing Centre (NIC) in Zwolle.

Friday September 29 2000
Delft Instruments in talks with Hit Group
Delft Instruments N.V. announces that it is engaged in negotiations with Hit Groep B.V. on the sale of its operating company MPP. Mechanical Parts Production B.V. (MPP) is an ISO 9002 and AQAP 120 certified manufacturer of precision components, modules and instruments for Delft Instruments companies.

Thursday August 24 2000
Delft Instruments H1 net NLG 1.6 m
Delft Instruments achieved net sales of NLG 165.4 mln during the first six months of 2000, down 1.1% on the figure of NLG 167.2 mln for the same period last year. Adjusted for the net sales of the Dutch and Italian defence activities which were sold on October 31, 1999, net sales were up 3.2%. The net operating result amounted to NLG 9.8 mln, a near 10% rise on the NLG 9.0 mln reported for the same period in 1999.

Thursday July 13 2000
Delft Instruments invests in medical programme
Delft Instruments said on Thursday that its subsidiary Nucletron has launched a major long-term investment programme for the treatment of prostate cancer using the seed implant method, placing small radioactive sources permanently into the prostate. Nucletron is market leader in the field of brachytherapy afterloaders, a treatment method involving the implantation of radioactive sources close to or actually within the tumour to be treated for varying lengths of time, Delft Instruments said.

Thursday March 23 2000
Delft Instruments returns to black figures
Delft Instruments reported on Thursday net profit for 1999 came to NLG 10.7 mln, compared with a net loss of NLG 43.7 mln the company booked in the comparible period of 1998. Turnover increased 8% from NLG 379.9 mln to NLG 410.8 mln. Operating income rose from NLG 6.4 mln to NLG 31.6 mln. The recovery followed a year of extensive restructuring during which Delft sold the bulk of its defence operations and two other units.

Thursday December 23 1999
Delft Instruments finalises defence sale
Delft Instruments announced on Thursday that it has reached final agreement with Hollandse Signaalapparaten on the sale of its Dutch and Italian defence activities. Delft Instruments said that the sale would generate a modest book profit to its 1999 result. The defence activities were deconsolidated and transferred to their new owner with effect from 1 November 1999.

Thursday November 25 1999
Delft Instruments acquires stake in software company
Delft Instruments announced on Thursday that it has taken a 35% stake in Rogan Medical Systems of Zeist for an undisclosed sum in cash. Rogan Medical Systems develops software for picture archiving and communication systems used to store and to transmit images from x-ray machines, CT scanners and other medical equipment. The company has 11 employees. Financial details were not disclosed.

Wednesday November 3 1999
Delft Instruments sells defence activities
Industrial electronics concern Delft Instruments is to divest the bulk of its defence activities to Hollandse Signaalapparaten for an undisclosed sum. The deal is due to be completed before the end of the year. Delft Instruments said it is selling its Dutch and Italian defence units to concentrate on its core medical and industrial activities.The subsidiaries being sold are Delft InstrumentsElectro-Optics in Delft and Oldelft Electronic Instruments in Rome which have combined annual turnover of between NLG 15 and NLG 20 mln.

Wednesday August 25 1999
Delft Instruments H1 in the black
Delft Instruments reported on Wednesday net profit for the first-half of 1999 came to NLG 1.4 mln, compared with net profit of NLG 10.4 mln (including an extra-ordinary income of NLG 14.7 mln) the company booked in the comparible period of 1998. Adjusted for the external sales generated by ODLeeuwarden, which was disposed of with effect from 1 January 1999, sales were 1% higher.

Monday August 2 1999
Delft Instruments rejects bid for DEP
Delft Instruments announced on Monday that it has aborted the talks with Burle Industries of the US on the sale of Delft's subsidiary Delft Electronic Products (DEP) of Roden. Delft Instruments said it could not reach agreement on the conditions of the sale. DEP develops and produces miniature lenses for night-vision equipment, security systems and microscopes.

Monday May 31 1999
Delft Instruments receives credit extension
Delft Instruments announced on Monday that it has reached an agreement with its banks concerning the continuation of credit lines. The agreement takes into account the existing borrowing requirement and the targeted reduction in the company's balance sheet. The negotiations between Delft Instruments and ABN Amro, ING and Fortis were necessary because by end-1998 the company no longer complied with all the required ratios for its loans.

Thursday May 27 1999
Delft Instruments wins Indonesian order
Delft Instruments announced on Thursday that its subsidiary Nucletron has won an order from the Indonesian health ministry for the supply and installation of complete radiotherapy units for nine hospitals on the islands of Java, Sumatra and Sulawesi. The value of the order is some NLG 45 mln. Delivery is due in 1999 and 2000. Nucletron will also provide local supervision for the construction of a number of facilities and training of personnel.

Wednesday April 28 1999
Delft Instruments sells image unit
Delft Instruments is discussing with Burle Industries of the US, the sale of its Roden, The Netherlands-based subsidiary Delft Electronic Products (DEP). The deal is expected to be finalised in May. Delft Instruments said that the intended sale underscores Delft Instruments' wish to release capital to re-invest in the expansion of its Medical and Industrial activities.

Friday April 23 1999
Delft Instruments sells headquarters
Delft Instruments has sold its headquarters in an effort to reduce its debts, the company said on Friday. The transaction, which is valued at NLG 7 mln, will be used to help pay off interest on loans amounting to NLG 222 mln. The company's management is moving to another location.

Thursday March 25 1999
Delft Instruments in the red
Delft Instruments reported on Thursday a net loss for 1998 of NLG 43.7 mln, compared with net profit of NLG 14.3 mln the company booked in the comparible period of 1997. A reorganisation charge of over NLG 50 mln caused the company to plunge deep in the red. Turnover decreased 20% from NLG 473.2 mln to NLG 379.9 mln.

Wednesday February 10 1999
Delft Instruments sells ODLeeuwarden
Delft Instruments has sold its production facility ODLeeuwarden to Manaus Holding. The transaction will be back-dated to January 1, 1999. Delft Instruments said ODLeeuwarden was no longer part of its core activities. ODLeeuwarden is a high-tech supplier and specialized in precision sheet metal work, electronics and final assembly of complete systems. Financial details were not disclosed.

Friday January 29 1999
Delft Instruments net loss NLG 5.8 mln
In the preliminary figures for 1998, Delft Instruments reports a net loss on ordinary activities after taxation of NLG 5.8 mln, compared with a net profit of NLG 14.2 mln for 1997. Including extraordinary items the company will book a net loss of NLG 43 mln. Delft Instruments specially blamed disappointing results at its subsidiary Nucletron.

Wednesday November 18 1998
Delft Instruments acquires Indian firm
Delft Instruments has acquired the Indian distributor Nucletron which sells, installs and maintains radiotherapy equipment. Details of the deal were not disclosed. Delft Instruments said that the acquired activities, together with the 18 employees, will be transferred to a new company to be incorporated for this purpose.

Monday October 12 1998
Delft Instruments reorganises
Delf Instruments plans to eliminate 140 of its more than 1,200 jobs as part of a move to increase profitability. Delft Instruments added it would sell off about 25% of the company, consisting of low profit units with combined annual turnover of NLG 500 mln. The company said the reorganisation now took the highest priority, adding that forced dismissals were inevitable. Of the 120 jobs to be scrapped, 20 are the company's operations abroad.

Wednesday August 26 1998
Delft Instruments in the red
Delft Instruments said on Wednesday it had a disappointing first-half. The company reported a net loss from ordinary operations of NLG 4.3 mln, compared with a profit of NLG 3.3 mln for the comparible period of 1997. Including an extraordinary gain of NLG 14.7 mln, net profit for the first-half of 1998 rose by NLG 7.4 mln to NLG 10.4 mln, compared with net profit of NLG 3.0 mln the company booked in the comparible period of 1997.

Friday August 14 1998
Delft Instruments signs co-operation agreements
Delft Instruments said on Friday its subsidiary Nucletron has signed co-operation agreements with both Siemens Medical Systems and ELEKTA Oncology Systems of Crawley, UK. The agreement with Siemens Medical Systems involves the marketing of Nucletron's treatment planning software and its branchytherapy systems.

Thursday March 26 1998
Delft Instruments reports net profit up 11%
Delft Instruments reports net profit for 1997 increased with 11% from NLG 12.9 mln to 14.3 mln. Turnover increased with 1% from NLG 467 mln to NLG 473 mln. The medical division booked sales 9% higher and operating profit was more than doubled at NLG 29 mln. The sale of Enraf-Nonius brought a book profit of NLG 15 mln.

Friday March 6 1998
Delft Instruments to sell Enraf-Nomius
Delft Instruments is to sell its Enraf-Nonius unit to Henley of the US. The sale will produce a NLG 15 mln book profit for Delft Instruments. Delft Instruments will provide Henley with a NLG 9 mln subordinated loan to finance the transaction. Henley and Enraf-Nonius both produce physiotherapy equipment. Henley has a strong position in the US, while Enraf-Nomius has a good market position in Europe, the Middle East and Asia. The companies books annual takeover of some NLG 75 mln each.

Thursday January 8 1998
Enraf-Nonius logistics to move to Frans Maas
The Delft Instruments subsidiary, Enraf-Nonius, Brunssum, which currently has 63 employees, is to undergo further reorganisation. The assembly and logistics departments of Enraf-Nonius are situated at this branch. Enraf-Nonius is active in the field of physiotherapy and has experienced a clear decline in sales in recent years as a result of market stagnation.

Hebels Financial Website believes the information herein was obtained from reliable sources but does not guarantee its accuracy. Neither the information nor any opinion expressed constitutes a solicitation of the purchase or sale of securities, derivatives or commodities. © 2002 Hebels Financial Website